| ||||||||||||||
|
|
|||||||||||||




*Département dAnesthésie-Réanimation, Centre Hospitalo-Universitaire (CHU) Avicenne, Bobigny;
Département dAnesthésie-Réanimation, CHU Pitié-Salpêtrière, Paris;
Département dAnesthésie-Réanimation, CHU Cochin, Paris;
Département dAnesthésie-Réanimation A, Hôpital Lapeyronie, CHU de Montpellier, Montpellier; ||Département dAnesthésie-Réanimation, Hôpital Saint Joseph, Paris; ¶Département dAnesthésie-Réanimation, CHU de CaenCôte de Nacre, Caen; and #Département dAnesthésie-Réanimation, CHU Trousseau, Paris, France
Address correspondence and reprint requests to Charles Marc Samama, Département dAnesthésie-Réanimation, Hôpital Avicenne 125, Route de Stalingrad, 93009 Bobigny Cedex, France. Address e-mail to cmsamama{at}invivo.edu
We conducted a prospective, multicenter, double-blinded, dose-ranging study to compare the risk/benefit ratio of large- and small-dose aprotinin with placebo after major orthopedic surgery. Fifty-eight patients were randomized into three groups: Large-Dose Aprotinin (4 M kallikrein inactivator unit [KIU] bolus before surgery followed by a continuous infusion of 1 M KIU/h until the end of surgery), Small-Dose Aprotinin (2 M KIU bolus plus 0.5 M KIU/h), and Placebo. Bleeding was measured and calculated. Bilateral ascending venography was systematically performed on the third postoperative day. Measured and calculated blood loss decreased in the Large-Dose Aprotinin group (calculated bleeding, whole blood, hematocrit 30%, median [range], 2,023 mL [6334,113] as compared with placebo, 3,577 mL [1,67021,758 mL]). The total number of homologous and autologous units was also significantly decreased in the Large-Dose Aprotinin group (2 U [05 U] as compared with placebo, 4 U [042 U]). No increase in deep vein thrombosis or pulmonary embolism was observed in the aprotinin groups. Large-dose aprotinin was safe and effective in dramatically reducing the measured and calculated bleeding and the amount of transfused red blood cell units after major orthopedic surgery.
IMPLICATIONS: Large doses of aprotinin decrease blood loss and transfusion amount in major orthopedic surgery.
This article has been cited by other articles:
![]() |
F. Bakaeen, D. Rice, A. M. Correa, G. L. Walsh, A. A. Vaporciyan, J. B. Putnam, S. G. Swisher, J. A. Roth, J. Huh, D. Chu, et al. Use of Aprotinin in Extrapleural Pneumonectomy: Effect on Hemostasis and Incidence of Complications Ann. Thorac. Surg., September 1, 2007; 84(3): 982 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Veres, T. Radovits, H. Schultz, L.-n. Lin, J. Hutter, E. Weigang, Z. Szabolcs, and G. Szabo Effect of recombinant aprotinin on postoperative blood loss and coronary vascular function in a canine model of cardiopulmonary bypass Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 340 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Royston, J. H. Levy, J. Fitch, W. Dietrich, S. C. Body, J. M. Murkin, B. D. Spiess, and A. Nadel Full-Dose Aprotinin Use in Coronary Artery Bypass Graft Surgery: An Analysis of Perioperative Pharmacotherapy and Patient Outcomes Anesth. Analg., November 1, 2006; 103(5): 1082 - 1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Fischer and M. Steinhoff Effects of aprotinin on endothelium-dependent relaxation of large coronary arteries Eur. J. Cardiothorac. Surg., December 1, 2005; 28(6): 801 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shiga, Z. Wajima, T. Inoue, and A. Sakamoto Aprotinin in Major Orthopedic Surgery: A Systematic Review of Randomized Controlled Trials Anesth. Analg., December 1, 2005; 101(6): 1602 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kokoszka, P. Kuflik, F. Bitan, A. Casden, and M. Neuwirth Evidence-Based Review of the Role of Aprotinin in Blood Conservation During Orthopaedic Surgery J. Bone Joint Surg. Am., May 1, 2005; 87(5): 1129 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Mahdy and N. R. Webster Perioperative systemic haemostatic agents Br. J. Anaesth., December 1, 2004; 93(6): 842 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.V. Gadhinglajkar, K.G. Shyamkrishnan, R. Sreedhar, and H. Sonwalkar Delayed thrombosis of left internal jugular vein and left subclavian vein: complication related to drainage of left superior vena cava Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 607 - 610. [Abstract] [Full Text] [PDF] |
||||
|